A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients with Advanced Kidney Cancer
Trial ID: NCT04088500
A clinical trial that all metastatic kidney cancer patients should know about if they have previously taken the combination of nivolumab and ipilimumab.
The study will investigate whether the combination can be used in patients a second time, even after they have already stopped responding to the treatment at an earlier time point.